Ignite Creation Date:
2025-12-24 @ 9:33 PM
Ignite Modification Date:
2026-05-30 @ 1:59 PM
Study NCT ID:
NCT01490632
Status:
COMPLETED
Last Update Posted:
2019-09-27
First Post:
2011-12-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
14455
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |